Retina/Vitreous News

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Baruch D. Kuppermann, MD, PhD, comments on the decision of the European Medicines Agency to reject the appeal for the approval of pegcetacoplan.

Aviceda Therapeutics has completed enrollment of its phase 2b SIGLEC study, which will compare the safety and efficacy of AVD-104 vs. Izervay in patients with geographic atrophy secondary to age-related macular degeneration.

BARCELONA, Spain — In this Healio Video Perspective from the ESCRS meeting, Federico Badalà, MD, shares his experience with the EyeMax Mono IOL in patients with insignificant cataract and dry age-related macular degeneration.

The FDA granted fast track designation to brepocitinib for the treatment of nonanterior noninfectious uveitis, according to a press release from Priovant Therapeutics.

BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Anat Loewenstein, MD, MHA, Euretina president, gives an overview of the variety of topics discussed here and the initiatives launched by the society.

BARCELONA, Spain — In this Healio Video Perspective, Jean-François Korobelnik, MD, PhD, discusses the decision of the European Medicines Agency to reject marketing authorization of pegcetacoplan in Europe.

The Committee for Medicinal Products for Human Use of the European Medicines Agency confirmed its negative opinion on the marketing authorization application for intravitreal pegcetacoplan for geographic atrophy.

Oral gildeuretinol acetate did not meet the primary endpoint of geographic atrophy lesion growth rate in a phase 3 study, according to a press release from Alkeus Pharmaceuticals.

ATSN-201 received orphan drug designation from the FDA for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.

Patients with preclinical Alzheimer’s disease had significantly greater putative retinal gliosis compared with controls, according to study results published in Investigative Ophthalmology & Visual Science.